Streamex Corp. Form 8-K Summary
Business Context and Reporting Period
Streamex Corp. (formerly BioSig Technologies, Inc.), a Delaware corporation, filed this Current Report on Form 8-K on November 4, 2025. The filing documents the reconvening of a special meeting of stockholders to finalize voting on a previously adjourned acquisition proposal.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on corporate governance and transactional events.
Material Changes
The primary material event is the successful approval and closing of the acquisition of Streamex Exchange Corporation ("Streamex"). Stockholders approved the issuance of approximately 109,070,079 shares of common stock and one share of Super Voting Preferred Stock to effectuate the transaction.
Voting Results and Transaction Details
- Proposal: Approval of the Acquisition Proposal (Proposal 1).
- For: 16,386,371 votes.
- Against: 267,215 votes.
- Abstain: 27,673 votes.
- Broker Non-Votes: 0.
- Outcome: The proposal was approved, and the acquisition has officially closed.
The Company also provided supplemental business information via an investor presentation (Exhibit 99.1) during the special meeting, which is furnished but not deemed "filed" under the Exchange Act.
Investor Verification Checklist
- Verify the final share count and dilution impact of the 109,070,079 newly issued shares.
- Review the definitive proxy statement (filed August 4, 2025, with amendments) for full terms of the Share Purchase Agreement.
- Examine Exhibit 99.1 for the supplemental business presentation regarding the acquired entity.
- Confirm the post-closing capital structure, including the issuance of Super Voting Preferred Stock.